FI905575A0 - Ny polypeptidfoerening och foerfarande foer dess framstaellning. - Google Patents

Ny polypeptidfoerening och foerfarande foer dess framstaellning.

Info

Publication number
FI905575A0
FI905575A0 FI905575A FI905575A FI905575A0 FI 905575 A0 FI905575 A0 FI 905575A0 FI 905575 A FI905575 A FI 905575A FI 905575 A FI905575 A FI 905575A FI 905575 A0 FI905575 A0 FI 905575A0
Authority
FI
Finland
Prior art keywords
polypeptidfoerening
hydrogen
foerfarande foer
och foerfarande
hydroxy
Prior art date
Application number
FI905575A
Other languages
English (en)
Inventor
Toshiro Iwamoto
Akihiko Fujie
Kumiko Nitta
Yasuhisa Tsurumi
Nobuharu Shigematsu
Chiyoshi Kasahara
Motohiro Hino
Masakuni Okuhara
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI905575A0 publication Critical patent/FI905575A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Stringed Musical Instruments (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI905575A 1989-11-13 1990-11-12 Ny polypeptidfoerening och foerfarande foer dess framstaellning. FI905575A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898925593A GB8925593D0 (en) 1989-11-13 1989-11-13 Fr901379 substance and preparation thereof

Publications (1)

Publication Number Publication Date
FI905575A0 true FI905575A0 (fi) 1990-11-12

Family

ID=10666207

Family Applications (1)

Application Number Title Priority Date Filing Date
FI905575A FI905575A0 (fi) 1989-11-13 1990-11-12 Ny polypeptidfoerening och foerfarande foer dess framstaellning.

Country Status (19)

Country Link
US (1) US5502033A (fi)
EP (1) EP0431350B1 (fi)
JP (1) JP3111470B2 (fi)
KR (1) KR910009729A (fi)
CN (1) CN1051757A (fi)
AT (1) ATE125550T1 (fi)
AU (1) AU6655790A (fi)
CA (1) CA2029766A1 (fi)
DE (1) DE69021176T2 (fi)
DK (1) DK0431350T3 (fi)
ES (1) ES2075115T3 (fi)
FI (1) FI905575A0 (fi)
GB (1) GB8925593D0 (fi)
HU (1) HUT58820A (fi)
IE (1) IE904072A1 (fi)
IL (1) IL96272A0 (fi)
NO (1) NO904904L (fi)
PT (1) PT95876A (fi)
ZA (1) ZA908892B (fi)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5386009A (en) * 1990-03-19 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
US5330973A (en) * 1990-03-19 1994-07-19 Merck & Co., Inc. Lipopeptide derivatives
IL98506A (en) * 1990-06-18 1996-09-12 Fujisawa Pharmaceutical Co Peptides, of antibiotics, processes for their preparation and pharmaceutical preparations containing them
US5428009A (en) * 1990-07-16 1995-06-27 Merck & Co., Inc. Lipopeptide derivatives
USH1638H (en) * 1990-11-08 1997-03-04 Furuta; Takahisa Use of the polypeptide compound
EP0486011A3 (en) * 1990-11-16 1992-07-15 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical composition against pneumocystis carinii
US5385884A (en) * 1991-08-27 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
AU681119B2 (en) * 1993-05-17 1997-08-21 Fujisawa Pharmaceutical Co., Ltd. New polypeptide compound and a process for preparation thereof
US5516757A (en) * 1994-09-16 1996-05-14 Merck & Co., Inc. Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use
US5516756A (en) * 1994-10-31 1996-05-14 Merck & Co., Inc. Aza cyclohexapeptide compounds
AU691743B2 (en) * 1995-01-26 1998-05-21 Merck & Co., Inc. Novel antifungal cyclohexapeptides
JP3123078B2 (ja) 1996-03-08 2001-01-09 藤沢薬品工業株式会社 環状リポペプチド物質の脱アシル化法
WO1997047738A1 (fr) * 1996-06-13 1997-12-18 Fujisawa Pharmaceutical Co., Ltd. Acylase des lipopeptides cycliques
US5696084A (en) * 1996-08-16 1997-12-09 Abbott Laboratories Amino-lipopetide antifungal agents
AUPO371596A0 (en) * 1996-11-19 1996-12-12 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPO691897A0 (en) * 1997-05-21 1997-06-12 Fujisawa Pharmaceutical Co., Ltd. New compound
US6319757B1 (en) * 1998-07-08 2001-11-20 Caldus Semiconductor, Inc. Adhesion and/or encapsulation of silicon carbide-based semiconductor devices on ceramic substrates
WO2001092578A2 (en) * 2000-05-26 2001-12-06 Board Of Trustees Of The University Of Illinois Reagents and methods for identifying and modulating expression of genes regulated by retinoids
WO2002068456A1 (en) * 2001-02-26 2002-09-06 Fujisawa Pharmaceutical Co., Ltd. Echinocandin derivatives, pharmaceutical compositions containing same and use thereof as drugs
AUPS188302A0 (en) * 2002-04-22 2002-05-30 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical composition
US7459290B1 (en) 2004-03-30 2008-12-02 Iowa State University Research Foundation, Inc. Methods of using functional 30S subunits
BRPI0820409A2 (pt) 2007-10-29 2015-05-19 Astellas Pharma Inc Composto de polipeptídeo
JP5387567B2 (ja) * 2008-03-14 2014-01-15 アステラス製薬株式会社 環状化合物およびその塩
JP6000254B2 (ja) * 2010-09-29 2016-09-28 上海天偉生物制薬有限公司 環状リポペプチド化合物又はその塩の精製方法
AU2011307733B2 (en) * 2010-09-30 2015-03-26 Shanghai Techwell Biopharmaceutical Co., Ltd. Method for purifying cyclic lipopeptide or salt thereof
CN102485879A (zh) * 2010-12-03 2012-06-06 上海医药工业研究院 一种用于生产wf11899a的发酵培养基
CN102533551B (zh) * 2010-12-15 2013-10-09 上海天伟生物制药有限公司 一种肽类抗生素的高产菌株及其制备方法和用途
CN102618604B (zh) * 2011-01-31 2014-09-03 上海天伟生物制药有限公司 一种环脂肽化合物的制备方法
CN102952179B (zh) * 2011-08-24 2015-11-25 华北制药集团新药研究开发有限责任公司 一种高纯度米卡芬净前体化合物的制备方法
CN102627689B (zh) 2012-03-30 2014-08-06 上海天伟生物制药有限公司 一种环肽类化合物的水合物及其制备方法和用途
CN102659930B (zh) 2012-03-30 2014-04-23 上海天伟生物制药有限公司 一种高纯度环肽类物质的晶体及其制备方法和用途
CN102627688B (zh) 2012-03-30 2014-12-31 上海天伟生物制药有限公司 一种高纯度环肽化合物及其制备方法和用途
CN103387975A (zh) 2012-05-11 2013-11-13 上海天伟生物制药有限公司 一种固定化环脂肽酰基转移酶及其制备方法和用途
CN103848900B (zh) * 2012-12-04 2015-12-02 上海医药工业研究院 一种从发酵液中分离纯化wf11899a的方法
CN114874919B (zh) * 2022-05-09 2023-06-27 中国科学院青岛生物能源与过程研究所 一株米卡芬净前体fr901379高产菌株及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4320053A (en) * 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912D nucleus
US4322338A (en) * 1979-12-13 1982-03-30 Eli Lilly And Company Derivatives of A-30912B nucleus
CA1182812A (en) * 1979-12-13 1985-02-19 Bernard J. Abbott Process for the preparation of derivatives of cyclic peptide nuclei
CA1159450A (en) * 1979-12-13 1983-12-27 Manuel Debono Process for the preparation of derivatives of cyclic peptide nuclei
US4320052A (en) * 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912A nucleus
US4287120A (en) * 1979-12-13 1981-09-01 Eli Lilly And Company Derivatives of S31794/F-1 nucleus
EP0311193B1 (en) * 1987-10-07 1993-12-01 Merck & Co. Inc. Antifungal fermentation product
DK173802B1 (da) * 1988-09-12 2001-11-05 Merck & Co Inc Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner
US5330973A (en) * 1990-03-19 1994-07-19 Merck & Co., Inc. Lipopeptide derivatives
IL98506A (en) * 1990-06-18 1996-09-12 Fujisawa Pharmaceutical Co Peptides, of antibiotics, processes for their preparation and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
ES2075115T3 (es) 1995-10-01
HU907105D0 (en) 1991-05-28
DK0431350T3 (da) 1995-09-11
DE69021176D1 (de) 1995-08-31
ZA908892B (en) 1991-09-25
JP3111470B2 (ja) 2000-11-20
AU6655790A (en) 1991-05-16
DE69021176T2 (de) 1996-01-11
NO904904D0 (no) 1990-11-12
CA2029766A1 (en) 1991-05-14
CN1051757A (zh) 1991-05-29
EP0431350B1 (en) 1995-07-26
HUT58820A (en) 1992-03-30
IE904072A1 (en) 1991-05-22
IL96272A0 (en) 1991-08-16
US5502033A (en) 1996-03-26
KR910009729A (ko) 1991-06-28
JPH03184921A (ja) 1991-08-12
NO904904L (no) 1991-05-14
ATE125550T1 (de) 1995-08-15
GB8925593D0 (en) 1990-01-04
EP0431350A1 (en) 1991-06-12
PT95876A (pt) 1991-09-13

Similar Documents

Publication Publication Date Title
FI905575A0 (fi) Ny polypeptidfoerening och foerfarande foer dess framstaellning.
FI912873A (fi) Ny polypeptidfoerening och foerfarande foer dess framstaellning.
FI893359A0 (fi) Fr 901228-foerening och foerfarande foer dess framstaellning.
AU6199494A (en) New polypeptide compound and a process for preparation thereof
IL96643A0 (en) Morpholinyl derivatives of doxorubicin,their preparation and pharmaceutical compositions containing them
FI891581A (fi) Peptidderivat.
AU6582394A (en) Novel bisoxadiazolidine derivative
MY111439A (en) Thymosin alpha 1 derivatives

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: FUJISAWA PHARMACEUTICAL CO., LTD.